Higher concentrations may offer some stability advantages in certain formulations because the peptide-to-surface ratio is more favorable, but they can also increase the risk of aggregation if the formulation is not optimized for that concentration
Most patients experience mild to moderate nausea during the first 12 weeks of a new dose
Research-Referenced Functional Attributes (Based on existing preclinical and literature datanot intended as claims of therapeutic use) High-affinity binding to HGF and potentiation of c-Met activation in the presence of subthreshold HGF concentrations in cellular assays (DOI: 10.1124/jpet.114.218735) Induction of synaptogenesis and dendritic spine formation through HGF/c-Met pathway augmentation in neuronal models Observation of PI3K/AKT signaling modulation in APP/PS1 mouse models (DOI: 10.3389/fnagi.2021.748253) Investigation of neuroregenerative signaling mechanisms in scopolamine-induced impairment paradigms Examination of synaptic protein expression markers in aging or stress-challenged experimental systems Examination of oral bioavailability and blood-brain barrier penetration in rodent studies
M.T., O.P.L., A.H., and S.S
The combination of a low dosage of both finerenone and empagliflozin in an animal model of hypertension-induced end-organ damage revealed efficacious reduction in proteinuria, plasma creatinine and uric acid, blood pressure, cardiac and renal lesions, and mortality [206]
